Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Chong, Ho-Chun Song, J. Min, S. Jeong, Jung-Min Ha, Jahae Kim, S. Yoo, Jong-Ryool Oh, H. Bom (2010)
Improved Detection of Lung or Bone Metastases with an I-131 Whole Body Scan on the 7th Day After High-Dose I-131 Therapy in Patients with Thyroid CancerNuclear Medicine and Molecular Imaging, 44
A. Esfahani, B. Fallahi, Reza Olamaie, M. Eftekhari, D. Beiki, M. Saghari (2004)
Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment.Hellenic journal of nuclear medicine, 7 3
Hasan Raza, A. Khan, Abid Hameed, Ayub Khan (2006)
Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphyNuclear Medicine Communications, 27
MARIE Carlisle, I. McDougall (2000)
Dramatic Parotid Uptake of I-131 on a Diagnostic Whole-Body ScanClinical Nuclear Medicine, 25
M. Schlumberger, Massimo Torlantano (2000)
Papillary and follicular thyroid carcinoma.Bailliere's best practice & research. Clinical endocrinology & metabolism, 14 4
M. Çağlar, M. Tuncel, R. Alpar (2002)
Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine TreatmentClinical Nuclear Medicine, 27
S. Mandel, L. Mandel (2003)
Radioactive iodine and the salivary glands.Thyroid : official journal of the American Thyroid Association, 13 3
P. Allweiss, G. Braunstein, A. Katz, A. Waxman (1984)
Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 25 7
K. Creach, B. Siegel, B. Nussenbaum, P. Grigsby (2012)
Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary MicrocarcinomaISRN Endocrinology, 2012
R. Rigler, P. Scanlon (1955)
Radiation parotitis from radioactive iodine therapy.Proceedings of the staff meetings. Mayo Clinic, 30 8
C. Alexander, J. Bader, A. Schaefer, C. Finke, C. Kirsch (1998)
Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 39 9
A. Macioszek, M. Bączyk, T. Kopeć, J. Sowiński (2008)
[Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].Endokrynologia Polska, 59 5
Young-Sil An, Joon-Kee Yoon, Su Lee, Hee-Sung Song, S. Yoon, K. Jo (2013)
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancerAnnals of Nuclear Medicine, 27
K. Yi, E. Lee, Ho-Cheol Kang, Yunwoo Koh, S. Kim, I. Kim, D. Na, K. Nam, S. Park, J. Park, S. Bae, S. Baek, J. Baek, Byung-Joo Lee, K. Chung, Yuh-Seog Jung, G. Cheon, W. Kim, J. Chung, Y. Rho (2016)
Guidelines for Patients with Thyroid Nodules and Thyroid Cancer
J. Kang, S. Jang, W. Lee, S. Jang, Y. Lee, Sang Kim (2011)
Evaluation of Salivary Gland Dysfunction Using Salivary Gland Scintigraphy in Sjögren’s Syndrome Patients and in Thyroid Cancer Patients after Radioactive Iodine TherapyNuclear Medicine and Molecular Imaging, 45
P. Lind (1999)
131I whole body scintigraphy in thyroid cancer patients.The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology, 43 3
Sang Lee, J. Lee, S. Kim, S. Han, W. Bae (2013)
Prediction of risk for symptomatic sialadenitis by post-therapeutic dual 131I scintigraphy in patients with differentiated thyroid cancerAnnals of Nuclear Medicine, 27
M. Prendes, A. Harris, B. Wirostko, Austin Gerber, B. Siesky (2013)
The role of transforming growth factor β in glaucoma and the therapeutic implicationsBritish Journal of Ophthalmology, 97
S. Hyer, A. Kong, Brenda Pratt, Clive Harmer (2007)
Salivary gland toxicity after radioiodine therapy for thyroid cancer.Clinical oncology (Royal College of Radiologists (Great Britain)), 19 1
Jae Kim, G. Han, Seung Lee, Dong Lee, Young-Mo Kim (2007)
Sialoendoscopic Treatment for Radioiodine Induced SialadenitisThe Laryngoscope, 117
R. Cavalieri (1997)
Iodine metabolism and thyroid physiology: current concepts.Thyroid : official journal of the American Thyroid Association, 7 2
M. Walter, C. Turtschi, C. Schindler, P. Minnig, J. Müller-Brand, B. Müller (2007)
The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort StudyJournal of Nuclear Medicine, 48
B. Malpani, A. Samuel, S. Ray (1996)
Quantification of salivary gland function in thyroid cancer patients treated with radioiodine.International journal of radiation oncology, biology, physics, 35 3
J. Woolfenden (2006)
Thyroid stunning revisited.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 47 9
Christine Spitzweg, K. Harrington, Lori Pinke, R. Vile, John Morris (2001)
Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy.The Journal of clinical endocrinology and metabolism, 86 7
E. Mazzaferri, S. Jhiang (1994)
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.The American journal of medicine, 97 5
IRIS KOLLA, N. Alazraki, N. Watts (1989)
Sialadenitis Mimicking Metastatic Thyroid CarcinomaClinical Nuclear Medicine, 14
D. Cooper, Gerard Doherty, B. Haugen, R. Kloos, Stephanie Lee, S. Mandel, E. Mazzaferri, B. Mciver, F. Pacini, M. Schlumberger, S. Sherman, D. Steward, R. Tuttle (2009)
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid : official journal of the American Thyroid Association, 19 11
MJ Schlumberger (1998)
Papillary and follicular thyroid carcinomaN Engl J Med, 338
Nucl Med Mol Imaging (2014) 48:203–211 DOI 10.1007/s13139-014-0274-4 ORIGINAL ARTICLE Significance of Salivary Gland Radioiodine Retention on Post-ablation I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid Carcinoma Kyung Sook Jo & Young-Sil An & Su Jin Lee & Euy-Young Soh & Jeonghun Lee & Yoon-Sok Chung & Dae Jung Kim & Seok-Ho Yoon & Dong Hyun Lee & Joon-Kee Yoon Received: 14 January 2014 /Revised: 23 March 2014 /Accepted: 26 March 2014 /Published online: 24 April 2014 Korean Society of Nuclear Medicine 2014 Abstract parotid glands, the TWS+ group showed larger Δuptake and Purpose We investigated whether I whole-body scintigra- Δwashout after radioiodine therapy than did the TWS- group (all phy could predict functional changes in salivary glands after p values <0.01). In contrast, the Δuptake and Δwashout of the radioiodine therapy. submandibular glands did not significantly differ between the Methods We evaluated 90 patients who received initial high- TWS+ and TWS- groups (all p values >0.05). Likewise, no dose (≥3.7 GBq) radioiodine therapy after total thyroidecto- differences in Δuptake or Δwashout were apparent between my. All patients underwent diagnostic (DWS) and post- the DWS+ and DWS- groups in either the parotid or
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Apr 24, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.